Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pro Medicus Limited ( (AU:PME) ) has provided an update.
Pro Medicus Limited has disclosed a small increase in the shareholding of director Anthony Barry Hall, who acquired 2,270 additional ordinary shares in an on-market trade at $220.31 per share. Following the transaction, Hall’s total relevant interest in Pro Medicus has risen to 24,148,520 ordinary shares held across various personal, superannuation and family trust structures, underscoring continued insider confidence and maintaining his significant stake in the company.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$350.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is an Australian healthcare technology company that develops and supplies medical imaging IT solutions, including radiology information systems and picture archiving and communication systems, primarily for hospitals, imaging centres and healthcare networks. The company focuses on delivering advanced diagnostic imaging software to improve clinical workflows and support healthcare providers in Australia and international markets.
YTD Price Performance: -12.93%
Average Trading Volume: 174,615
Technical Sentiment Signal: Hold
Current Market Cap: A$22.72B
For a thorough assessment of PME stock, go to TipRanks’ Stock Analysis page.